To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

Modified Wily Coyote entices non-US users

29th October 2021 - 10:30 GMT | by Grzegorz Sobczak

RSS

The PZL-made M28 Special Operations Multi-Role Aircraft (SOMA) is a version of the US-specific MC-145B special mission support aircraft. (Photo: Grzegorz Sobczak)

A new variant of the MC-145B Wily Coyote light attack aircraft lacks certain US SOF-specific equipment but retains its weaponry.

Lockheed Martin-owned PZL Mielec and Sierra Nevada Corporation (SNC) displayed the M28 Special Operations Multi-Role Aircraft (SOMA) on 26 October in Poland, to coincide with the start of the GSOF Symposium Europe in Warsaw.

SOMA is a version of the MC-145B Wily Coyote light attack aircraft — itself derived from the C-145A Combat Coyote operated by USAF Special Operations Command (AFSOC) and one of five candidate solutions being evaluated by AFSOC in the Armed Overwatch programme.

The Polish-made variant is geared for sales to non-US SOF. SOMA therefore lacks some of the US SOF-specific sensors aboard the other versions.

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 1 free story per week
  • Personalised news alerts
  • Daily and weekly newsletters
  • Free magazine subscription to all our titles
  • Downloadable equipment data handbooks
  • Distribution rights (Corporate only)
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
  • 10-year news archive access
  • Downloadable equipment data handbooks
  • Distribution rights (Corporate only)
Start your free trial

Share to

Linkedin